Mark R. Wallace
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mark R. Wallace has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
A. Velazquez
Infectious Disease, Orlando Health, Orlando, FL, USA
1 shared publication- Alexander Velazquez
Department of Infectious Disease, Orlando Health, Orlando, FL USA
1 shared publication Anthony LaRocco
Department of Internal Medicine (Infectious Disease Division), Naval Hospital, San Diego
1 shared publication- Beata Raczynski
Department of Infectious Disease, Orlando Health, Orlando, FL USA
1 shared publication Bob Ly
A Skagit Valley Hospital , Mt Vernon , WA , USA
1 shared publicationBrittany Fries
Pharmacy, Orlando Health, Orlando, FL
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report
Waldenström macroglobulinemia (WM) and essential thrombocythemia (ET) are distinct hematologic malignancies that have only been reported to co‐occur in one previous patient. We present a 64‐year‐old man with a significant family history for WM who was found to have both ET and WM. He had symptomatic ET, diagnosed by elevated platelets and a positive JAK2 V617F mutation, and asymptomatic WM was found on serum electrophoresis done for screening due to family history. Genomic evaluation of the myeloid and lymphoid cells suggested independent neoplastic transformation. This is the second reported case of a patient with both WM and ET. There was no evidence for a shared mechanism in these dual malignancies.
- 1 January 2025
- Published by Wiley in Case Reports in Hematology
- Vol. 2025 (1)
Open AccessCoexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report
Waldenström macroglobulinemia (WM) and essential thrombocythemia (ET) are distinct hematologic malignancies that have only been reported to co‐occur in one previous patient. We present a 64‐year‐old man with a significant family history for WM who was found to have both ET and WM. He had symptomatic ET, diagnosed by elevated platelets and a positive JAK2 V617F mutation, and asymptomatic WM was found on serum electrophoresis done for screening due to family history. Genomic evaluation of the myeloid and lymphoid cells suggested independent neoplastic transformation. This is the second reported case of a patient with both WM and ET. There was no evidence for a shared mechanism in these dual malignancies.
- Open Access
- 23 March 2020
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2020, 1-2
HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstroms macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have emerged as a major complication of therapy. While fungal infections have been the most problematic (including CNS aspergillosis), zoster, hepatitis B reactivation, and chronic hepatitis E have been reported in association with ibrutinib therapy. This report describes a case of herpes encephalitis in an 86-year-old Waldenstroms patient receiving ibrutinib and speculates as to whether this late life encephalitis may have been related to ibrutinib.
- 23 March 2020
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2020, 1-2
Open AccessHSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstroms macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have emerged as a major complication of therapy. While fungal infections have been the most problematic (including CNS aspergillosis), zoster, hepatitis B reactivation, and chronic hepatitis E have been reported in association with ibrutinib therapy. This report describes a case of herpes encephalitis in an 86-year-old Waldenstroms patient receiving ibrutinib and speculates as to whether this late life encephalitis may have been related to ibrutinib.
- Open Access
- 27 June 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (7) , ofz300
Response to: A Retrospective Forensic Review of Unexpected Infectious Deaths
- 27 June 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (7) , ofz300
Open AccessResponse to: A Retrospective Forensic Review of Unexpected Infectious Deaths
- 17 July 2017
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (1) , 75-76
Dalbavancin as a cost effective antibiotic
(2018). Dalbavancin as a cost effective antibiotic. Infectious Diseases: Vol. 50, No. 1, pp. 75-76.
- 17 July 2017
- Published by Taylor & Francis in Infectious Diseases
- Vol. 50 (1) , 75-76
Dalbavancin as a cost effective antibiotic
(2018). Dalbavancin as a cost effective antibiotic. Infectious Diseases: Vol. 50, No. 1, pp. 75-76.
- Open Access
- 1 December 2014
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 1 (suppl_1) , S15-S16
134Implement of a Mandatory Infectious Disease Consultation for Staphylococcus aureus Bacteremia
Background. Staphylococcus aureus bacteremia (SAB) continues to be a major cause of morbidity and mortality. ID consultation has been advocated to optimize care. Mandatory ID consultation was implemented at Orlando Health in August 2012 after we found evidence of improved outcomes with ID consultation in a prior study.
- 1 December 2014
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 1 (suppl_1) , S15-S16
Open Access134Implement of a Mandatory Infectious Disease Consultation for Staphylococcus aureus Bacteremia
Background. Staphylococcus aureus bacteremia (SAB) continues to be a major cause of morbidity and mortality. ID consultation has been advocated to optimize care. Mandatory ID consultation was implemented at Orlando Health in August 2012 after we found evidence of improved outcomes with ID consultation in a prior study.
- Open Access
- 2 October 2014
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2014, 1-5
Hepatic Lesions with Secondary Syphilis in an HIV-Infected Patient
Syphilis among HIV-infected patients continues to be a public health concern, especially in men who have sex with men. The clinical manifestations of syphilis are protean; syphilitic hepatitis is an unusual complication that can occur at any stage of the disease. We report a case of an HIV-infected male who presented with systemic symptoms and liver lesions highly suggestive of lymphoma and was proven to have syphilitic hepatitis by liver biopsy. Our case reinforces the importance of recognizing syphilis as a possible cause of unexplained abnormal liver enzymes and/or hepatic lesions in HIV-infected patients.
- 2 October 2014
- Published by Hindawi Limited in Case Reports in Medicine
- Vol. 2014, 1-5
Open AccessHepatic Lesions with Secondary Syphilis in an HIV-Infected Patient
Syphilis among HIV-infected patients continues to be a public health concern, especially in men who have sex with men. The clinical manifestations of syphilis are protean; syphilitic hepatitis is an unusual complication that can occur at any stage of the disease. We report a case of an HIV-infected male who presented with systemic symptoms and liver lesions highly suggestive of lymphoma and was proven to have syphilitic hepatitis by liver biopsy. Our case reinforces the importance of recognizing syphilis as a possible cause of unexplained abnormal liver enzymes and/or hepatic lesions in HIV-infected patients.
- Open Access
- 30 December 2013
- Published by Springer Nature in SpringerPlus
- Vol. 2 (1) , 696
The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections
Background: Empiric therapy of inpatient skin and soft tissue infections (SSTIs) generally require methicillin resistant Staphylococcus aureus (MRSA) coverage. Limited data are available to directly compare the effect of initial antibiotic choice on treatment outcomes and length of stay (LOS). Objective: To assess potential differences in length of hospital stay when inpatients with complex skin and soft tissue infections (SSTIs) were initially treated with either vancomycin, linezolid, or daptomycin. Methods: A retrospective review of 219 patients diagnosed with inpatient SSTI who received linezolid, vancomycin, or daptomycin for >48 hours was performed. Data collected included demographics, comorbidities, microbiologic/laboratory data, additional management (surgical, non-study antibiotics), hospital LOS, treatment outcome and morbidity/mortality. Results: The three groups evaluated were linezolid (n = 45), vancomycin (n = 90) daptomycin (n = 84). There was no difference between the three groups with respect to gender, age, comorbidities, leukocytosis, fever, antibiotics prior to admission, site of infection culture results and surgical intervention. One death was recorded, not associated with diagnosis of SSTI. No significant difference in LOS was found (P = 0.525) between the 3 groups. The mean LOS in entire cohort was 4.5 days (SD ± 2.5); thirty patients had prolonged LOS for non-SSTI reasons; reanalyzing the data without these 30 patients did not produce any difference in the mean LOS between the 3 groups. Switching vancomycin just prior to discharge to facilitate outpatient therapy was common but did not impact LOS. Conclusions: No difference was detected in hospital length of stay with respect to the initial choice of antibiotic (linezolid, vancomycin, or daptomycin) for SSTI. The three antibiotic regimens were equally effective in treating SSTIs as judged by LOS, irrespective of age, gender, comorbidities or baseline severity of SSTI. Given the large standard deviation in LOS, this result should be confirmed by larger studies.
- 30 December 2013
- Published by Springer Nature in SpringerPlus
- Vol. 2 (1) , 696
Open AccessThe impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections
Background: Empiric therapy of inpatient skin and soft tissue infections (SSTIs) generally require methicillin resistant Staphylococcus aureus (MRSA) coverage. Limited data are available to directly compare the effect of initial antibiotic choice on treatment outcomes and length of stay (LOS). Objective: To assess potential differences in length of hospital stay when inpatients with complex skin and soft tissue infections (SSTIs) were initially treated with either vancomycin, linezolid, or daptomycin. Methods: A retrospective review of 219 patients diagnosed with inpatient SSTI who received linezolid, vancomycin, or daptomycin for >48 hours was performed. Data collected included demographics, comorbidities, microbiologic/laboratory data, additional management (surgical, non-study antibiotics), hospital LOS, treatment outcome and morbidity/mortality. Results: The three groups evaluated were linezolid (n = 45), vancomycin (n = 90) daptomycin (n = 84). There was no difference between the three groups with respect to gender, age, comorbidities, leukocytosis, fever, antibiotics prior to admission, site of infection culture results and surgical intervention. One death was recorded, not associated with diagnosis of SSTI. No significant difference in LOS was found (P = 0.525) between the 3 groups. The mean LOS in entire cohort was 4.5 days (SD ± 2.5); thirty patients had prolonged LOS for non-SSTI reasons; reanalyzing the data without these 30 patients did not produce any difference in the mean LOS between the 3 groups. Switching vancomycin just prior to discharge to facilitate outpatient therapy was common but did not impact LOS. Conclusions: No difference was detected in hospital length of stay with respect to the initial choice of antibiotic (linezolid, vancomycin, or daptomycin) for SSTI. The three antibiotic regimens were equally effective in treating SSTIs as judged by LOS, irrespective of age, gender, comorbidities or baseline severity of SSTI. Given the large standard deviation in LOS, this result should be confirmed by larger studies.
- 1 December 2013
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 19 (12) , 1169-1172
Daptomycin non-susceptible Staphylococcus aureus at a US medical centre
- 1 December 2013
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 19 (12) , 1169-1172
Daptomycin non-susceptible Staphylococcus aureus at a US medical centre
- Open Access
- 4 April 2013
- Published by Wiley in Case Reports in Medicine
- Vol. 2013, 1-4
Puerperal Group A Streptococcal Infections: A Case Series and Discussion
Puerperal group A streptococcal infections, a major postpartum killer during the late 19th and early 20th centuries, have become (fortunately) rare. We describe a cluster of 4 serious peripartum group A streptococcal infections occurring within the past five years at a single medical center. These cases were not epidemiologically linked and serve to illustrate the continuing risk of these potentially fulminant infections.
- 4 April 2013
- Published by Wiley in Case Reports in Medicine
- Vol. 2013, 1-4
Open AccessPuerperal Group A Streptococcal Infections: A Case Series and Discussion
Puerperal group A streptococcal infections, a major postpartum killer during the late 19th and early 20th centuries, have become (fortunately) rare. We describe a cluster of 4 serious peripartum group A streptococcal infections occurring within the past five years at a single medical center. These cases were not epidemiologically linked and serve to illustrate the continuing risk of these potentially fulminant infections.
- 1 September 2012
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 20 (5) , 349-350
Prosector’s Streptococcal Pharyngitis
A forensic pathologist, wearing appropriate protective gear, developed streptococcal pharyngitis 3 days after performing an autopsy on a young woman who had died of necrotizing group A streptococcal soft tissue infection. The Streptococcus pyogenes isolates from the deceased and the pathologist proved to be an identical emm 89 strain. Transmission of pathogens from cadavers during medical procedures is rare. This case illustrates the underappreciated but real risk of health care workers acquiring invasive strains of S. pyogenes from patients, including the recently deceased.
- 1 September 2012
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 20 (5) , 349-350
Prosector’s Streptococcal Pharyngitis
A forensic pathologist, wearing appropriate protective gear, developed streptococcal pharyngitis 3 days after performing an autopsy on a young woman who had died of necrotizing group A streptococcal soft tissue infection. The Streptococcus pyogenes isolates from the deceased and the pathologist proved to be an identical emm 89 strain. Transmission of pathogens from cadavers during medical procedures is rare. This case illustrates the underappreciated but real risk of health care workers acquiring invasive strains of S. pyogenes from patients, including the recently deceased.